These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 30066289)

  • 1. Inhibition of NF-κB Reduces Renal Inflammation and Expression of PEPCK in Type 2 Diabetic Mice.
    Liu Q; Zhang L; Zhang W; Hao Q; Qiu W; Wen Y; Wang H; Li X
    Inflammation; 2018 Dec; 41(6):2018-2029. PubMed ID: 30066289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NF-κB Inhibitor Parthenolide Promotes Renal Tubules Albumin Uptake in Type 2 Diabetic Nephropathy.
    Hao QF; Wang BB; Zhang W; Qiu W; Liu QL; Li XM
    Chin Med Sci J; 2020 Mar; 35(1):31-42. PubMed ID: 32299536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oleanolic acid improves hepatic insulin resistance via antioxidant, hypolipidemic and anti-inflammatory effects.
    Wang X; Liu R; Zhang W; Zhang X; Liao N; Wang Z; Li W; Qin X; Hai C
    Mol Cell Endocrinol; 2013 Aug; 376(1-2):70-80. PubMed ID: 23791844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pck1 gene silencing in the liver improves glycemia control, insulin sensitivity, and dyslipidemia in db/db mice.
    Gómez-Valadés AG; Méndez-Lucas A; Vidal-Alabró A; Blasco FX; Chillon M; Bartrons R; Bermúdez J; Perales JC
    Diabetes; 2008 Aug; 57(8):2199-210. PubMed ID: 18443203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphoenolpyruvate carboxykinase in urine exosomes reflect impairment in renal gluconeogenesis in early insulin resistance and diabetes.
    Sharma R; Kumari M; Prakash P; Gupta S; Tiwari S
    Am J Physiol Renal Physiol; 2020 Mar; 318(3):F720-F731. PubMed ID: 32036699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the novel Foxo1 inhibitor AS1708727 on plasma glucose and triglyceride levels in diabetic db/db mice.
    Tanaka H; Nagashima T; Shimaya A; Urano Y; Shimokawa T; Shibasaki M
    Eur J Pharmacol; 2010 Oct; 645(1-3):185-91. PubMed ID: 20655898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphoenolpyruvate carboxykinase (GTP) gene transcription and hyperglycemia are regulated by glucocorticoids in genetically obese db/db transgenic mice.
    Friedman JE; Sun Y; Ishizuka T; Farrell CJ; McCormack SE; Herron LM; Hakimi P; Lechner P; Yun JS
    J Biol Chem; 1997 Dec; 272(50):31475-81. PubMed ID: 9395482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amelioration of glucose tolerance by hepatic inhibition of nuclear factor kappaB in db/db mice.
    Tamura Y; Ogihara T; Uchida T; Ikeda F; Kumashiro N; Nomiyama T; Sato F; Hirose T; Tanaka Y; Mochizuki H; Kawamori R; Watada H
    Diabetologia; 2007 Jan; 50(1):131-41. PubMed ID: 17093946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenobarbital reduces blood glucose and gluconeogenesis through down-regulation of phosphoenolpyruvate carboxykinase (GTP) gene expression in rats.
    Oda H; Okuda Y; Yoshida Y; Kimura N; Kakinuma A
    Biochem Biophys Res Commun; 2015 Oct; 466(3):306-11. PubMed ID: 26348778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dapagliflozin Aggravates Renal Injury via Promoting Gluconeogenesis in db/db Mice.
    Jia Y; He J; Wang L; Su L; Lei L; Huang W; Geng X; Zhang S; Meng X; Zhou H; Yang B
    Cell Physiol Biochem; 2018; 45(5):1747-1758. PubMed ID: 29495021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel anti-diabetic effect of SCM-198 via inhibiting the hepatic NF-κB pathway in db/db mice.
    Huang H; Xin H; Liu X; Xu Y; Wen D; Zhang Y; Zhu YZ
    Biosci Rep; 2012 Apr; 32(2):185-95. PubMed ID: 21859425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular signaling mechanisms of renal gluconeogenesis in nondiabetic and diabetic conditions.
    Swe MT; Pongchaidecha A; Chatsudthipong V; Chattipakorn N; Lungkaphin A
    J Cell Physiol; 2019 Jun; 234(6):8134-8151. PubMed ID: 30370538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of hepatic neuregulin 4 in the regulation of gluconeogenesis in mice.
    Zhang L; Bai M; Tang H; Zhou F; Zhu Q; Wang S; Zhu K; Liu Q; Liu Y; Wang X; Ma Y; Zhou L
    Life Sci; 2019 Jan; 217():185-192. PubMed ID: 30528184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Celastrol, an NF-κB inhibitor, improves insulin resistance and attenuates renal injury in db/db mice.
    Kim JE; Lee MH; Nam DH; Song HK; Kang YS; Lee JE; Kim HW; Cha JJ; Hyun YY; Han SY; Han KH; Han JY; Cha DR
    PLoS One; 2013; 8(4):e62068. PubMed ID: 23637966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An insulin-independent mechanism for transcriptional regulation of Foxo1 in type 2 diabetic mice.
    Ge W; Zhao Y; Yang Y; Ding Z; Xu X; Weng D; Wang S; Cheng R; Zhang J
    J Biol Chem; 2021 Jul; 297(1):100846. PubMed ID: 34058194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes.
    Liu TY; Shi CX; Gao R; Sun HJ; Xiong XQ; Ding L; Chen Q; Li YH; Wang JJ; Kang YM; Zhu GQ
    Clin Sci (Lond); 2015 Nov; 129(10):839-50. PubMed ID: 26201094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The novel anti-hyperglycemic effect of Paeoniae radix via the transcriptional suppression of phosphoenopyruvate carboxykinase (PEPCK).
    Juan YC; Tsai WJ; Lin YL; Wang GJ; Cheng JJ; Yang HY; Hsu CY; Liu HK
    Phytomedicine; 2010 Jul; 17(8-9):626-34. PubMed ID: 20096551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia increases the rate of renal gluconeogenesis via hypoxia-inducible factor-1-dependent activation of phosphoenolpyruvate carboxykinase expression.
    Owczarek A; Gieczewska K; Jarzyna R; Jagielski AK; Kiersztan A; Gruza A; Winiarska K
    Biochimie; 2020; 171-172():31-37. PubMed ID: 32045650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin suppresses hepatic gluconeogenesis through induction of SIRT1 and GCN5.
    Caton PW; Nayuni NK; Kieswich J; Khan NQ; Yaqoob MM; Corder R
    J Endocrinol; 2010 Apr; 205(1):97-106. PubMed ID: 20093281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential hypoglycemic effect of 2,5-anhydro-D-mannitol, a putative gluconeogenesis inhibitor, in genetically diabetic (db/db) and streptozotocin-induced diabetic mice.
    Kodama H; Fujita M; Yamaguchi I
    Jpn J Pharmacol; 1994 Nov; 66(3):331-6. PubMed ID: 7869620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.